173 related articles for article (PubMed ID: 20217448)
1. Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.
Sonnenblick A; Meirovitz A
Int J Clin Oncol; 2010 Aug; 15(4):420-2. PubMed ID: 20217448
[TBL] [Abstract][Full Text] [Related]
2. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group.
Moosmann N; von Weikersthal LF; Vehling-Kaiser U; Stauch M; Hass HG; Dietzfelbinger H; Oruzio D; Klein S; Zellmann K; Decker T; Schulze M; Abenhardt W; Puchtler G; Kappauf H; Mittermüller J; Haberl C; Schalhorn A; Jung A; Stintzing S; Heinemann V
J Clin Oncol; 2011 Mar; 29(8):1050-8. PubMed ID: 21300933
[TBL] [Abstract][Full Text] [Related]
4. [A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].
Nakano M; Kameyama H; Shimada Y; Hashimoto Y; Hosoi M; Nakano M; Nogami H; Hanyu T; Takizawa K; Ishikawa T; Sakata J; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Wakai T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1785-7. PubMed ID: 25731329
[TBL] [Abstract][Full Text] [Related]
5. Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab.
Shaikh A; Wiisanen ME; Gunderson HD; Leung N
Ann Pharmacother; 2009 Jul; 43(7):1370-3. PubMed ID: 19584382
[TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
7. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
Glynne-Jones R; Mawdsley S; Harrison M
Acta Oncol; 2010 Apr; 49(3):278-86. PubMed ID: 20180626
[TBL] [Abstract][Full Text] [Related]
8. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
10. [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].
Zhao WY; Chen DY; Qi Q
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):295-8. PubMed ID: 21575503
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters.
Ku GY; Haaland BA; de Lima Lopes G
Cancer Chemother Pharmacol; 2012 Aug; 70(2):231-8. PubMed ID: 22699811
[TBL] [Abstract][Full Text] [Related]
12. [A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy].
Yamanashi T; Nishi T; Yamamoto T; Toriumi F; Koshida Y; Mukai K; Shimoyama Y
Gan To Kagaku Ryoho; 2014 Jan; 41(1):107-12. PubMed ID: 24423963
[TBL] [Abstract][Full Text] [Related]
13. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
[No Abstract] [Full Text] [Related]
14. Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy.
Lieuw-a-Fa M; Peringa J; Leeksma O; Terpstra W
J Clin Oncol; 2008 Mar; 26(8):1381-2. PubMed ID: 18323561
[No Abstract] [Full Text] [Related]
15. [Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].
Guo GF; Xia LP; Qiu HJ; Xu RH; Zhang B; Jiang WQ; Zhou FF; Wang F
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):777-81. PubMed ID: 21163071
[TBL] [Abstract][Full Text] [Related]
16. Combined cetuximab, capecitabine, oxaliplatin, and radiotherapy in rectal cancer: Dr. Jekyll or Mr. Hyde? In regard to Rödel et al. (Int J Radiat Oncol Biol Phys 2008;70:1081-1086.).
Azria D
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):959-60; author reply 960. PubMed ID: 18514789
[No Abstract] [Full Text] [Related]
17. Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
Cartwright T; Kuefler P; Cohn A; Hyman W; Berger M; Richards D; Vukelja S; Nugent JE; Ruxer RL; Boehm KA; Asmar L
Clin Colorectal Cancer; 2008 Nov; 7(6):390-7. PubMed ID: 19036692
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
[TBL] [Abstract][Full Text] [Related]
19. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Mohammed TA; Dennie T; Holen KD
Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
[No Abstract] [Full Text] [Related]
20. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
[No Abstract] [Full Text] [Related]
[Next] [New Search]